Pharma finally moves toward greater trial data transparency

Despite GlaxoSmithKline and Roche Holding's move to make patient-level trial data available online, studies involving off-label use are not being listed, said Peter Doshi, an associate editor at the British Medical Journal and an assistant professor at the University of Maryland School of Pharmacy. The FDA should take an active interest in data transparency as the European Medicines Agency is doing, Doshi said.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY